Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment

OBJECTIVE: Changes in progranulin (GRN) expression have been hypothesized to alter risk for Alzheimer's disease (AD). We investigated the relationship between GRN expression in peripheral blood and clinical diagnosis of AD and mild cognitive impairment (MCI). METHODS: Peripheral blood progranul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Yonatan A., Nachun, Daniel, Dokuru, Deepika, Yang, Zhongan, Karydas, Anna M., Serrero, Ginette, Yue, Binbin, Boxer, Adam L., Miller, Bruce L., Coppola, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945969/
https://www.ncbi.nlm.nih.gov/pubmed/29761124
http://dx.doi.org/10.1002/acn3.560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945969/
https://www.ncbi.nlm.nih.gov/pubmed/29761124
http://dx.doi.org/10.1002/acn3.560

Ejemplares similares